Sorted By:

Relevance


PhRMA Applauds Nomination of Kathleen Sebelius as HHS Secretary

PhRMA  |  Press Release

Washington, D.C. (March 2, 2009) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today on Kathleen Sebelius’ selection as incoming Department of Health and Human Services Secretary: “Kansas Gov. K...
https://www.phrma.org/press-release/phrma-applauds-nomination-of-kathleen-sebelius-as-hhs-secretary

PhRMA Commends SCHIP Passage In Letter to House Speaker Nancy Pelosi

PhRMA  |  Press Release

Washington, D.C. (January 14, 2009) — The track record of success demonstrated by the State Children’s Health Insurance Program (SCHIP) would be continued – and expanded – by passage of the Children’s Health Insurance Program Reauthorization Act of 2009, said Billy Tauzin, presid...
https://www.phrma.org/press-release/phrma-commends-schip-passage-in-letter-to-house-speaker-nancy-pelosi

Rx Response Director Erin Mullen Receives Outstanding Achievement Award

PhRMA  |  Press Release

New Orleans, LA (March 27, 2013) – Rx Response Director and PhRMA Associate Vice President for IT & Operations Erin Mullen, PhD., RPh, CEM, received the Outstanding Achievement Award for Preparedness at the National Hurricane Conference in New Orleans today. Mullen was...
https://www.phrma.org/press-release/rx-response-director-erin-mullen-receives-outstanding-achievement-award

AstraZeneca’s Chip Davis Joins PhRMA To Assist Organization in Leadership Transition

PhRMA  |  Press Release

Washington, D.C. (April 7, 2010) — Chip Davis, Vice President of Corporate External Relations, AstraZeneca, is joining the Pharmaceutical Research and Manufacturers of America (PhRMA) as Senior Operating Officer to help with the Association’s leadership transition. Davis will rep...
https://www.phrma.org/press-release/astrazeneca-s-chip-davis-joins-phrma-to-assist-organization-in-leadership-transition

PhRMA Elects Four New Members to Board of Directors

PhRMA  |  Press Release

Ian Read, President and Chief Executive Officer, PfizerJerzy Gruhn, President, Novo Nordisk Inc.Mark Iwicki, President and Chief Operating Officer, Sunovion Pharmaceuticals Inc.Staffan Schüberg, President, Lundbeck Inc. Washington, D.C. (December 21, 2010...
https://www.phrma.org/press-release/phrma-elects-four-new-members-to-board-of-directors

Pilot Programs to Focus on Alzheimer’s Disease, Autoimmune Disorders and Type 2 Diabetes

PhRMA  |  Press Release

Washington, D.C. (February 4, 2014) – The Pharmaceutical Research and Manufacturers of America (PhRMA) has joined the National Institutes of Health (NIH),  10 biopharmaceutical companies and several non-profit disease foundations in a partnership to transform the current model fo...
https://www.phrma.org/press-release/pilot-programs-to-focus-on-alzheimer-s-disease-autoimmune-disorders-and-type-2-diabetes

PhRMA Statement on India Supreme Court Decision on Glivec

PhRMA  |  Press Release

WASHINGTON, D.C. (April 1, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani issued the following statement today: “PhRMA is very disappointed with the Indian Supreme Court’s decision to deny a patent on Glivec. This dec...
https://www.phrma.org/press-release/phrma-statement-on-india-supreme-court-decision-on-glivec

PhRMA Statement Regarding Prescription Drug User Fee Act Reauthorization

PhRMA  |  Press Release

As of 2009, the U.S. biopharmaceutical sector directly provided more than 650,000 jobs, supporting a total of about four million jobs in the United States.
https://www.phrma.org/press-release/phrma-statement-regarding-prescription-drug-user-fee-act-reauthorization

World Anti-Counterfeiting Day Puts Spotlight On Growing Foreign Counterfeit Medicine Threat

PhRMA  |  Press Release

Just as the G8 recently issued a declaration recognizing the threat of the growing counterfeit medicine trade, U.S. policymakers must focus on ways we can continue to protect our closed supply chain and prevent counterfeit medicines from harming American patients."
https://www.phrma.org/press-release/world-anti-counterfeiting-day-puts-spotlight-on-growing-foreign-counterfeit-medicine-threat

Over 8,200 Clinical Trials of Medicines Conducted by Texas Research Institutions Since 1999

PhRMA  |  Press Release

Anderson Cancer Center at the University of Texas, Houston Central Austin Cancer Center, Austin Lone Star Heart Center, Amarillo The Methodist Health Systems, San Antonio University of Texas Medical Branch, Galveston For a full listing of clinical trials that are recruiting patients and their locations within Texas as well as more information on clinical trials, please visit our Clinical Research and Trials resource page.
https://www.phrma.org/press-release/over-8-200-clinical-trials-of-medicines-conducted-by-texas-research-institutions-since-1999

U.S. is Still Most Attractive Country for Biopharma Investment; BRICs, Canada Lag Behind

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit:www.PhRMA.orgwww.FromHopetoCures.orgwww.Facebook.com/PhRMAwww.Twitter.com/PhRMA
https://www.phrma.org/press-release/u-s-is-still-most-attractive-country-for-biopharma-investment-brics-canada-lag-behind

PhRMA and BIO Initiate Litigation to Challenge Unconstitutional Provisions of Nevada’s SB 539

PhRMA  |  Press Release

Washington, DC (September 1, 2017) – The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) toda...
https://www.phrma.org/phrma-bio-release

PhRMA Response to Colombia’s Decision to Enforce a Declaration of Public Interest

PhRMA  |  Press Release

Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-response-to-colombias-decision-to-enforce-a-declaration-of-public-interest

PhRMA Statement on President Obama’s Debt Reduction Speech

PhRMA  |  Press Release

Castellani today released the following statement: "PhRMA firmly supports a viable, comprehensive policy framework to cultivate an environment that encourages innovative biopharmaceutical companies to remain and grow in the U.S.
https://www.phrma.org/press-release/phrma-statement-on-president-obama-s-debt-reduction-speech

PhRMA Statement on Medicare Part D Premiums

PhRMA  |  Press Release

The Medicare trustees, in their annual report released this month, reduced their estimate of future Part D spending compared to last year’s estimate.
https://www.phrma.org/press-release/phrma-statement-on-medicare-part-d-premiums1

Rodger Currie to Lead Advocacy Efforts at PhRMA

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA  
https://www.phrma.org/press-release/rodger-currie-to-lead-advocacy-efforts-at-phrma

PhRMA Statement on Inauguration of President Obama

PhRMA  |  Press Release

(To learn more about the platform, please visit www.phrma.org) “We look forward to continuing our dialogue on all of these important issues – and many more – with President Obama and members of the new Congress.”
https://www.phrma.org/press-release/phrma-statement-on-inauguration-of-president-obama

PhRMA Statement on Ensuring Continued Medical Progress

PhRMA  |  Press Release

(March 8, 2011) — A new report, “Emerging Biopharmaceutical Companies, Ensuring a Favorable Environment for Continued Innovation,” released today by the Pharmaceutical Research and Manufacturers of America (PhRMA), underscores the commitment of America’s biopharmaceutical research companies – of all sizes – to continued medical progress.
https://www.phrma.org/press-release/phrma-statement-on-ensuring-continued-medical-progress

PhRMA Honors Patient Advocates Ron and Raychel Bartek

PhRMA  |  Press Release

In fact, a 2006 report released by PhRMA and NORD found that more than 160 new medicines for these illnesses had been approved in the decade between 1995 and 2005, compared with 108 such approvals in the decade prior, and fewer than 10 in the 1970s.
https://www.phrma.org/press-release/phrma-honors-patient-advocates-ron-and-raychel-bartek

PhRMA Names Rajesh Ranganathan, Ph.D. as Vice President of Science and Regulatory Advocacy

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-names-rajesh-ranganathan-ph-d-as-vice-president-of-science-and-regulatory-advocacy

Nearly 1,000 Medicines in Development to Help Patients in Their Fight Against Cancer

PhRMA  |  Press Release

(May 31, 2012) — America’s biopharmaceutical research companies are testing 981 medicines and vaccines to fight the many types of cancer affecting millions of patients worldwide, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA).
https://www.phrma.org/press-release/nearly-1-000-medicines-in-development-to-help-patients-in-their-fight-against-cancer

New Report: Transforming Rare Disease Patients' Lives Through Innovation

PhRMA  |  Press Release

  Connect with PhRMA For information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/new-report-transforming-rare-disease-patients-lives-through-innovation

PhRMA Elects New Members of Board of Directors

PhRMA  |  Press Release

Connect with PhRMAFor information on how innovative medicines save lives, please visit: www.PhRMA.org www.FromHopetoCures.org www.Facebook.com/PhRMA www.Twitter.com/PhRMA
https://www.phrma.org/press-release/phrma-elects-new-members-of-board-of-directors

PhRMA Launches Campaign to Raise Awareness Of Success of Medicare Prescription Drug Benefit

PhRMA  |  Press Release

In March 2009, the non-partisan Congressional Budget Office (CBO) released new baseline spending projections that reduced its 10-year forecast for the total cost of the Medicare drug program by $520 billion, or 43 percent, compared with its 2006 estimate for the same 10-year period (FY 2007-2016).
https://www.phrma.org/press-release/phrma-launches-campaign-to-raise-awareness-of-success-of-medicare-prescription-drug-benefit

America’s Pharmaceutical Research Companies Donate $35 Million to Relief Efforts in Haiti, More Help Coming

PhRMA  |  Press Release

Washington, D.C. (January 29, 2010) — As the need for health care assistance mounts in Haiti after the recent catastrophic earthquake, America’s pharmaceutical research and biotechnology companies continue to provide help. So far, nearly $35 million in medicines, medical supplies...
https://www.phrma.org/press-release/america-s-pharmaceutical-research-companies-donate-35-million-to-relief-efforts-in-haiti-more-help-coming

You have reviewed the first 400 results out of 877. Each page contains 25 results. You're on page 16.

prev 13 14 15 16 17 18 next